as structure-directing agents (SDAs) (4). Since then, a wide range of OMSs, such as the hexagonal phases MCM-41 and SBA-15, have been prepared and investigated (4, 5) .
INTRODUCTION
Mesostructured materials belong to the class of nanomaterials, whose properties can be tailored at the nanometric scale. Specifically, according to IUPAC classification mesoporous solids are characterized by pores ranging within 2-50 nm (1) . These materials are generally obtained by coupling a sol-gel method, that is very effective to prepare glasses and ceramics at room temperature, with a supramolecular self-assembling process (2) . This particular approach is made possible by taking advantage of the hydrophobic/hydrophilic features of some molecules, i.e. surfactants, to prepare supramolecular aggregates, called micellae (3) .
The first successful synthesis of ordered mesostructured silicas (OMSs) was reported in the early 1990s, when Mobil Oil Corporation researchers used surfactants Mesoporous bioactive glass as a multifunctional system for bone regeneration and controlled drug release surgeons and materials scientists will be highly desirable and appreciated.
MATERIALS AND METHODS

Materials synthesis
In this work, a glass with ordered mesostructure was produced by coupling a traditional sol-gel method with the evaporation-induced self-assembly (EISA) process (25) , following the procedure previously reported by Yan et al. (26) . An amphiphilic triblock copolymer with sequence poly(ethylene glycole)-poly(propylene glycole)poly(ethylene glycole) (PEG-PPG-PEG), commercially called Pluronic 123 (P123), was used as a structure directing agent (SDA) (5) . Briefly, 2.0 g of P123 (M w = 5800 Da; Aldrich) were dissolved in 60.0 g of ethanol (99.5%, Sigma-Aldrich) and 1.0 g of 0.5 M HCl. After continuous magnetic stirring (~400 rpm) at 35°C for 1 h, until P123 is completely dissolved, the glass oxides precursors, i.e. 6.7 g of tetraethyl orthosilicate (TEOS; 98.0%, Sigma-Aldrich), bioactivity, that nevertheless can be opportunely induced. In fact, MCM-41 exhibited good bioactive behavior when its walls were doped with phosphorus (11) or by adding small amounts of bioactive glasses (12) . Composite systems formed by MCM-41 and bioactive glass-ceramic scaffolds, necessary to guarantee implant bioactivity, have also been recently proposed for bone tissue engineering (7) (8) (9) (10) .
The materials traditionally used for bone replacement, e.g. natural or synthetic hydroxyapatite (HA) (13) , calcium phosphates (14) , and bioactive glasses and glass-ceramics (BGs and BGCs) (15, 16) , which have been widely investigated since the early 1970s, are able to chemically bond to living bone without the formation of scar or fibrous tissue around the implant owing to the growth of a bonelike apatite layer on their surface during the course of the so-called "bioactivity process" (17) . In particular, BGs are glasses of complex composition containing modifier oxides, e.g. CaO, Na 2 O, and K 2 O, that locally interrupt the SiO 2 -based network. The bioactivity process is because of ion-exchange phenomena between the glass, which usually releases alkaline ions (Ca 2+ , Na + , K + ), and the solution or the biological fluids put into contact with the implant.
It is known that the formation of an apatite layer on sol-gel glasses surface is related both to the structure and to the composition of the material, whereas BGs obtained via traditional melting routes reveal a direct dependence only from the composition (18) . In fact, it was demonstrated that an increase in the specific surface area and pores volume in sol-gel BGs highly accelerates the HA formation kinetics, thereby enhancing the bone-bonding ability of the material (19, 20) . Recently, ordered SiO 2 -based mesoporous bioactive glasses (MBGs) have been synthesized by means of a combination of supramolecular chemistry and sol-gel process (21) (22) (23) . The potential carried by this new class of biomaterials is remarkable, and, for instance, the use of MBGs as drug release systems (21, 22) , bone fillers (23) and components of glass cements inducing accelerated in vitro apatite formation (24) have been proposed.
In this work, a MBG belonging to the SiO 2 -P 2 O 5 -CaO ternary system has been synthesized in different forms (powders and membranes of adjustable thickness) and its features have been investigated in detail by means of structural and morphologic analysis, in vitro bioactivity tests, and biological compatibility assay. In addition, the drug uptake and release ability of the material was assessed by using ibuprofen as a model drug. The major potential of the prepared MBG as a multifunctional material able to couple bone regeneration ability, by virtue of its excellent bioactivity, with drug release properties, was particularly highlighted. In addition, the easiness and versatility of shaping the MBG in the form of membranes could also carry valuable advantages from a surgical viewpoint, in an attempt to design and manufacture patient-designed bone grafts. In such a context, an ever better synergy between take ability was assessed by UV-visible spectrophotometry (Cary 500 Scan UV-vis spectrophotometer); specifically, the amount of ibuprofen absorbed by the sample was calculated from the difference in the concentration of drug in solution before and after contact with the sample, on the basis of the absorption at 263 nm, typical for ibuprofen molecules. Prior to analysis, the samples were centrifuged to avoid scattering effect because of MBG powders suspended in the solution. Test conditions were properly set in order to enable application of Lambert-Beer's law. A calibration curve was empirically derived by using solutions of ibuprofen in pentane of known concentrations.
Drug release kinetics were assessed in vitro by soaking the MBG powders in 30 mL of stirred SBF maintained at 37°C. At different time frames -from 1 h up to 72 h after the experiment commenced -a small amount of SBF (1 mL) was picked-up and analyzed by means of UV-visible spectrophotometry to assess the molecule concentration in the solution. A calibration curve was calculated by using solutions of ibuprofen in SBF of known concentrations, as well as for uptake tests. Prior to spectrophotometric analysis the samples were centrifuged to eliminate possible scattering errors because of the presence of residual glass powders in the analyzed solution.
Biological tests
MBG ground in powders was used for cells biocompatibility assay. Cells were not seeded directly on the material but a transwell-based method was adopted (30) . Cell viability was quantified by assessing their mitochondrial activity; possible effects of dose-dependence were also investigated by using different amounts of MBG powders (0.5, 1.0, 1.5, 2.0, and 3.0 mg). Incubation time was set at 24 h for all tests.
Human osteosarcoma cell line SAOS-2, obtained from the American Type Culture Collection (HTB85; ATCC), was used for the test. Cells were cultured in McCoy's 5A modified medium with 1.5 mM L-glutamine and 25 mM HEPES (Cambrex Bio Science, Baltimore, MD), supplemented with 15% fetal bovine serum, 1 mM sodium pyruvate, 100 IU/ mL penicillin, 100 mg/mL streptomycin, 10 -8 M dexamethasone and 10 mM β-glycerophosphate (Sigma-Aldrich, Milwaukee, WI); 2.84 mM ascorbic acid, another osteogenic supplement, was present as a component of McCoy's 5A modified medium. Cells were cultured at 37°C with 5% CO 2 , routinely trypsinized after reaching confluence conditions, counted, and finally seeded onto the culture wells.
MBG powders were sterilized by autoclave treatment (120°C for 20 min at 1 atm) before a cytotoxicity test. The materials were applied to the base of the transwells (6.5 mm in diameter, pores size of 0.4 μm) (Costar Transwell-Clear, Corning Costa, Cambridge, MA). To compare the relative toxicities of different materials, the transwells were transferred into 24-well culture plates that 0.73 g of triethyl phosphate (TEP; 99.8%, Sigma-Aldrich) and 1.4 g of calcium nitrate, Ca(NO 3 ) 2 ×4H 2 O (Sigma-Aldrich) (molar ratio Si/Ca/P = 80:15:5), were added to the synthesis batch (pH < 1.0). The batch was continuously stirred at 35°C for 24 h; then, the sol was cast into glass molds to undergo the EISA process at room temperature (RT). Gelation occurred after ~36 h; after seven days of ageing, the dried gels were carefully removed from the molds as transparent membranes and finally calcined at 700°C in air for 5 h (heating rate and cooling rate set at 1 and 10°C•min -1 respectively). The steps involved in the preparation of MBGs are summarized in Figure 1 .
Materials characterization
The MBG was investigated by means of wide-angle (2θ within 10-70°) and low-angle (2θ within 0.8-4°) x-ray diffraction (XRD, X'Pert Philips diffractometer with Bragg-Brentano camera, Cu anode, and Ka radiation); specifically, the latter was necessary to assess the mesostructure symmetry.
Compositional investigations on the samples before and after calcination were performed by energy dispersive spectroscopy (EDS; Philips Edax 9100); the samples were silver-coated prior to analysis.
Nitrogen (N 2 ) adsorption-desorption porosimetry measurements at 77 K (Quantachrome Autosorb1) were taken on the MBG ground in powders; in particular, the specific surface area (SSA) was assessed by using the Brunauer-Emmet-Teller (BET) method (27) , whereas the pores size distribution was determined from the desorption branch of the isotherm by means of the Broekhoff-de Boer (BdB) (28) and the BJH method (27) .
The structure and morphology of mesoporous channels were investigated in detail by means of transmission electron microscopy (TEM, Jeol JEM 3010 UHR operating at 300 kV).
In vitro bioactivity assessment involved soaking MBG membranes in 30 mL of acellular simulated body fluid (SBF) prepared according to the protocol proposed by Kokubo et al (29) . The different time frames selected for the analysis were 8, 24, 48 h, and 7 days, in order to assess the formation of HA on samples surface also during the first hours of immersion. The solution was replaced twice a week to simulate fluid circulation in the human body; pH variations were monitored daily.
Drug uptake and release
The drug loading/release ability of the MBGs was tested by using ibuprofen, that has been used as a model drug in previous works (7) (8) (9) (10) . Ibuprofen (99.9% purity, Sigma-Aldrich) was absorbed by putting a solution (9 mL) of ibuprofen in pentane (33 mg·ml -1 , 0.16 M) into contact with MBG powders for 24 h under continuous stirring. Drug up-
RESULTS AND DISCUSSION
Examples of as-synthesized MBG membranes are reported in Figures 2 a, b. After the extraction from the mold, the transparent membranes, characterized by thickness ranging within 300 to 500 μm, can be easily cut into various shapes, and, for instance, disk-shaped ( Fig. 2a ) or plug-shaped ( Fig. 2b) samples can be produced. The EDS spectrum of non-calcined membrane is reported in Figure  2c . It is possible to observe the peaks of silicon (Si), phosphorus (P), and calcium (Ca) because of glass oxides featuring material composition. In addition, an intense peak of carbon (C) is visible because the organic surfactant is still present inside the mesopores. The weak peak corresponding to chlorine (Cl) is because of Clions, provided by HCl entrapped in the glass structure. The presence of the silver (Ag) peak in the EDS pattern is because of the metal coating required for analysis.
Examples of MBG membranes obtained after calcination are shown in Figures 3 a, b. During calcination, the surfactant (P123) burns-out and the consolidation of the mesostructure is promoted: as is known, during this phase the pores walls become thicker and pore size decreases. The resulting calcined samples are brittle, semitransparent membranes of SiO 2 -P 2 O 5 -CaO glass, that maintain their original shape imparted prior to calcination. As foreseen, the calcined MBG membranes are thinner (thickness rang-were seeded with cells (2.5×10 5 cells/well) for 24 h before the respective powders were transferred to the transwells. The control group (CTRL) was represented by the cases in which powders were not transferred to the culture wells. Tests were performed on triplicate samples.
To assess the mitochondrial activity of the seeded cells, i.e. the viability of SAOS-2 cells during the culture period, a test with 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) (Sigma-Aldrich) was performed after incubation for 24 h. The culture medium was replaced by a 0.5 mg/mL solution of MTT in phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , pH=7.4) and the cell cultures were incubated for 4 h. The test is based on the fact that viable cells can reduce MTT into formazan crystals: when reduced in a cell, either enzymatically or by means of direct reaction with NADH/NADPH, MTT turns bright blue and forms a water-insoluble precipitate (formazan). After removing the MTT solution, 500 μL of dimethyl sulphoxide (Sigma-Aldrich) were added to solubilize the formazan products and the well plate containing the cells was shaken for 20 minutes on a shaker. Aliquots of 200 μL were sampled and the related absorbance values were measured at 570 nm by a microplate reader (BioRad Laboratories, Hercules, CA). A standard curve of cell viability was used to express results as a percentage of the total number of cells. ing within 100 to 300 μm) than the as-synthesized ones; the thickness reduction is because of the shrinkage that occurs during calcination. A very weak peak of carbon (C) is distinguishable in the EDS pattern ( Fig. 3c ), which demonstrates that the organic surfactant was almost totally removed. Thermogravimetric analyses (TGA/SDTA 851 instrument equipped with STARe 6.10 software, Mettler Toledo, Columbus, Ohio, USA; range of analysis 25°C to 1000°C, heating rate 20°C•min -1 ) were also performed (data not reported) to quantitatively assess the residue of surfactant and, therefore, to estimate the effectiveness of calcination. Specifically, the residual organic fraction that remained entrapped inside the pores was estimated to be <5 %wt. of the initial weight of the sample.
It is worth noting that the final thickness of the membranes can be easily tailored: in fact, the more the sol volume cast into the mold, the higher the thickness of the resulting MBG membrane. The linear shrinkage, approximately calculated on the basis of membrane thickness before and after calcination, ranged within 30% to 40%; this important point, related to MBG membranes design and tailoring, will be further discussed at the end of the following subsection.
Structural analysis
The wide-angle XRD pattern of calcined MBG is depicted in Figure 4 . The presence of a broad halo between 2θ ≈ 15.0° and 2θ ≈ 35.0° demonstrates that the material is completely amorphous. Figure 5 collects low-angle XRD investigations on the MBG before and after calcination. The spectrum of assynthesized MBG (Fig. 5a ) reveals a unique weak peak at 2θ≈0.93°. The existence of this peak demonstrates that an ordered structure of mesopores already existed in the non-calcined material, but the peak intensity was weak as the surfactant (P123) filled the on-forming mesopores. After calcination, when the SDA is removed, the basal peak because of the mesophase order is clearly distinguishable at 2θ≈1.35° (Fig. 5b ), together with a broad scattering at higher angles (2θ≈1.70°).
The mesophase symmetry is a crucial point and was determined by combining low-angle XRD results with TEM data that will presented in the following subsection. The structure of the prepared MBG was interpreted as a 2-D hexagonal symmetry, together with some disordered worm-like domains.
By comparing the patterns shown in Figure 5 , it can be observed that the position of the basal peak shifts towards a higher 2θ-value after calcination. This is because of shrinkage of the material during calcination, i.e. the surfactant burning-out, which yields a decrease in the interplanar distance.
From XRD data it is also possible to provide an assessment -although rather approximate -of the shrinkage because of calcination, which should be carefully taken into account for MBG membrane design and tailoring. Assuming the basal peak is the (1 0 0) reflection of the 2-D hexagonal phase, then * 100 d = 9.40 nm and 100 d = 6.50 nm are the interplanar distance of the non-calcined and calcined material, respectively. Hence, the cell parameters of the mesophase before and after calcination are, respectively, = 10.85 nm and = 7.50 nm. Eventually, the linear shrinkage lin S (%) can be calculated as = 29.1%; this value is consistent with the range assessed qualitatively by comparing the thickness of the MBG membranes before and after calcination. Under the assumption that the cell parameter is the characteristic dimension of the mesophase, an approximate assessment of the volumetric shrinkage vol S (%) can be finally obtained as = 66.9%. Knowing the shrinkage, the size of the mold and the volume of sol cast into the mold, it is possible -at least ideally -to design the shape and thickness of the final calcined MBG membrane, so that it can match the size and shape of the patient's bone defect. Mesopores characterization Figure 6 shows a typical IV type well-defined N 2 sorption isotherm for calcined MBG ground in powders. The three relevant regions of the adsorption branch, typically corresponding to (i) monolayer/multilayer adsorption onto the mesopores surface, (ii) capillary condensation and (iii) multilayer adsorption onto the particles external surface, are clearly distinguishable. As reported elsewhere, the shape of the hysteresis loop is closely related to the shape of mesopores (31) : in this case, the MBG channels have a well defined cylindrical shape with a diameter of ~5.0 nm (BdB and BJH methods led to very close results, as reported in Tab. I). Figure 7a depicts a section along the direction parallel to channels axes, that reveals a highly ordered arrangement of 1-D open, cylindrical, and parallel mesopores, as previously inferred from N 2 adsorption-desorption analysis. In Figure 7b the system of ordered parallel channels can be simultaneously seen both along the channels axes and orthogonally to them; the 2-D hexagonal symmetry of the ordered mesopores system is clearly distinguishable.
Pore size, calculated by means of N 2 adsorption-desorption measurements, is in good accordance with that assessed by TEM, as shown in Table I . In addition, the cell parameter calculated from TEM data (7.90 nm) is consistent with that determined by XRD analysis (7.50 nm).
It should be noted that the investigated MBG is not completely organized into ordered domains, but two different domains can be distinguished: (i) well-ordered regions according to a hexagonal symmetry and (ii) poorly ordered or disordered regions (worm-like domains).
The importance of a structure constituted by totally or partially ordered channels of nanometric size is relevant in a material to enhance its bioactivity. As previously discussed, the mesopores texture enables increasing the surface area (Tab. I) available for ion-exchange phenomena, thereby promoting the bioactivity process and the kinetics of HA formation. Figure 8 collects the SEM micrographs of MBG membrane surface after soaking for 8, 24, 48 h, and 7 days in SBF; the corresponding EDS spectra are also reported. After 8 h of immersion, globe-shaped agglomerates are already distinguishable on the MBG membrane (Fig. 8a) . The newly formed phase, whose formation is because of ion-exchange phenomena between the MBG and the solution, is apatitelike, as qualitatively assessed by the EDS spectrum reported in Figure 8b . An intense peak corresponding to silicon (Si) with up to 90 %mol. of SiO 2 , because of their high surface area, typically within 100 to 200 m 2 •g -1 (approximately two orders of magnitude higher than that of melt-derived glasses) (35, 36) . The excellent bioactive properties observed for the prepared MBG membranes can be explained considering that the nanoporous texture of the material plays a key role in enhancing its surface area. In fact, the system of mesoporous channels enhances the surface area up to still higher values (Tab. I) than those exhibited by sol-gel glasses. Therefore, the ion-exchange phenomena between MBG and SBF in vitro or between MBG and the biological fluids in vivo can be remarkably promoted. The presence of an ordered mesostructure significantly affects the bioactive properties of the glass and, generally, has more influence than glass chemical composition in the HA nucleation stage during the bioactivity process (23) .
In vitro bioactivity tests
The pH variation in the solution, resulting from ionexchanges with the material, is quite moderate (pH < 8.0; is clearly visible in the pattern and can be attributed to (i) the presence of a silica-gel layer, according to the bioactivity process proposed by Hench and co-workers (32, 33) and/or (ii) a substrate effect because of the finite volume of EDS analysis (~1 μm 3 ). The Si-peak gradually decreases in intensity as the soaking time increases (Figs. 8d and 8f ) and it is no more visible after seven days of soaking (Fig.  8h ). This demonstrates that the newly formed phase gradually grew in amount and thickness, and finally the typical "cauliflower" morphology of HA can be recognized after soaking for seven days (Fig. 8g) .
The quantitative EDS data reported in Table II show that the agglomerates visible on the membrane after 8 h of soaking in SBF can be identified as Ca-deficient HA (Ca/P = 1.51). The Ca content in the newly formed phase gradually rises as soaking time increases; after seven days, a molar Ca/P ratio of 1.67, corresponding to the stoichiometric Ca/P ratio of natural HA, was detected.
The XRD pattern reported in Figure 9 shows, as expected, several marked peaks assignable to the (0 0 2), (2 1 1), (3 0 0), (2 0 2), and (2 1 3) reflections of HA. The main (double) peak at 2θ≈32.0° is broad because of the microcrystalline nature of the HA nucleated on the MBG surface.
It is worth underlining that the prepared MBG membranes, although they have a silica content of 80% mol., are highly bioactive. Hench et al. demonstrated that, for traditional melt-derived glasses, the silica content has to be 60 %mol. or less to allow to bond with bone (34) . Nevertheless, bone bonding can be attained for sol-gel glasses of soaking and, therefore, before HA formation occurred. Hence, HA growth and ibuprofen release followed quite separate kinetics and, specifically, the material bioactivity does not negatively interfere with the MBG's drug release ability. After the first 24 h of analysis, the percentage of ibuprofen released seems to decrease gradually (from 96% after 24 h up to 93% after 50 h); this phenomenon may be explained considering that the material, after releasing most of the absorbed drug, can re-uptake a small amount. The MBG release kinetics are very similar to those obtained by Izquierdo-Barba et al. testing SBA-15 spheres (37) , that have mesopore sizes comparable to that of the prepared MBGs.
Biological compatibility and cytotoxicity
The mitochondrial activity of SAOS-2 cells was used as a reliable index to quantify their viability. Figure 11 reports the results after cell incubation for 24 in response to different MBG amounts. Control sample (CTRL; medium only without MBG powders) exhibits a cells viability of ~90% (< 100%); this occurs because a cell fraction (~10% in the present case) is damaged by the intrinsic oxidative stress because of cell manipulation during test procedures. reference value for SBF = 7.40), therefore, no cytotoxic effect induced by the material, when implanted, is foreseen.
Drug uptake and release ability
The potential of mesoporous materials to act as matrices for the encapsulation and subsequent release of drug molecules has been underlined in many research works, as the size of the mesopores can be designed to match, at least approximately, the sizes of a wide range of biomolecules. Since the material synthesized in this work exhibited a very high bioactivity with fast HA formation kinetics, it was very interesting to assess if such a property could negatively affect the MBG's drug release ability. In fact, one might reasonably hypothesize that the HA agglomerates, formed during immersion in SBF, can obstruct the mesoporous channels, thereby inhibiting -or strongly depressing -ibuprofen release from the material.
The test of ibuprofen uptake was performed in duplicate to monitor the test repeatability. Actually, the test was found to be highly repeatable, as the analyses on both samples led to analogous results. It was estimated that the material could absorb an ibuprofen amount equal to ~25 %wt. of its starting weight. This value is slightly higher than that obtained by Izquierdo-Barba et al. (37) who tested mesoporous materials belonging to the SBA-15 family characterized by mesopore size similar to that of the MBGs prepared in this work. The amount of ibuprofen absorbed by MBG powders was also found comparable to the data obtained testing mesophases with smaller pores, e.g. MCM-41 (8) (9) (10) , that should be expected to exhibit a higher affinity for ibuprofen molecules because of better dimensional matching between drug molecule length and pore size.
According to the uptake tests, the ibuprofen release tests were also performed in duplicate, and both of them led to similar results. Figure 10 shows the kinetics of ibuprofen delivery in SBF. Over 90% of the drug absorbed into the mesopores was released within the first two hours within its mesochannels. Ibuprofen release from MBG in SBF occurred with kinetics similar to that observed for pure silica mesophases with analogous pore size. Finally, the MBG exhibited excellent cell tolerance, without negatively affecting SAOS-2 cells viability during in vitro tests. Overall, the results suggest the potential use of the prepared MBG in bone tissue engineering as a bioactive drug release system suitable for bone defect fillers and controlled local drug therapy. 
